Ajooni Biotech Limited / Fundamentals

    Income statement

    Net revenue
    €10.25M
    Cost of goods sold
    €8.85M
    Gross profit
    €1.40M
    SG&A expenses
    €548.09K
    R&D expenses
    €0.00
    EBITDA
    €430.81K
    D&A
    €77.39K
    EBIT
    €848.25K
    Interest expenses
    €37.86K
    EBT
    €383.48K
    Tax expenses
    €117.18K
    Net income
    €266.30K

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€266.30K
    Changes in working capital
    €0.00
    Operating cash flow
    €0.00
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €0.00
    Debt repayment
    €0.00
    Other financing cash flow
    €0.00
    Net financing cash flow
    €0.00
    Foreign exchange effects
    €0.00
    Net change in cash
    €0.00
    Cash at end of period
    €0.00
    Free cash flow
    €0.00

    Balance sheet

    Cash and cash equivalents
    €1.72M
    Cash and short-term investments
    €1.72M
    Total receivables
    €2.13M
    Inventory
    €2.04M
    Other current assets
    €1.44M
    Total current assets
    €7.33M
    Property, plant & equipment
    €1.12M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €426.89K
    Other non-current assets
    €270.44K
    Total non-current assets
    €1.82M
    Total assets
    €9.14M
    Accounts payable
    €288.77K
    Short-term debt
    €0.00
    Other current liabilities
    €115.32K
    Total current liabilities
    €404.09K
    Long-term debt
    €201.22K
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €12.73K
    Total non-current liabilities
    €213.95K
    Total liabilities
    €618.04K
    Common stock
    €3.36M
    Retained earnings
    €0.00
    Other equity
    €5.16M
    Total equity
    €8.52M
    Total liabilities and shareholders' equity
    €9.14M

    Company information

    Market capitalization
    €10.22M
    Employees
    109
    Enterprise Value
    €777.82M

    Company ratios

    Gross margin
    13.6% Much worse than peer group: 36.6%
    EBITDA margin
    4.2% Even with peer group: 8.9%
    EBIT margin
    8.3% Even with peer group: 5.7%
    EBT margin
    3.7% Even with peer group: 4.1%
    Net margin
    2.6% Even with peer group: 3.3%
    ROE
    3.1% Even with peer group: 6.4%
    ROA
    2.9% Even with peer group: 4.4%
    Asset turnover
    112.1% Even with peer group: 114.8%
    FCF margin
    0.0%
    FCF yield
    0.0%
    Efficiency ratio
    95.8%
    Net sales per employee
    €94.02K
    Net income per employee
    €2.44K

    Notifications